| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,378 |
5,747 |
$264K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,516 |
5,740 |
$153K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,472 |
7,026 |
$124K |
| 80061 |
Lipid panel |
8,057 |
7,625 |
$108K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,695 |
12,704 |
$104K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,278 |
2,132 |
$63K |
| 80053 |
Comprehensive metabolic panel |
4,893 |
4,620 |
$52K |
| 82274 |
|
3,255 |
3,068 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,205 |
4,888 |
$42K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,341 |
4,108 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,791 |
1,497 |
$36K |
| 81000 |
|
10,939 |
10,301 |
$35K |
| 86738 |
|
1,525 |
1,439 |
$22K |
| 84153 |
|
1,178 |
1,111 |
$21K |
| 86701 |
|
2,274 |
2,157 |
$21K |
| 82607 |
|
1,116 |
1,049 |
$17K |
| 86702 |
|
1,422 |
1,264 |
$15K |
| 86328 |
|
763 |
743 |
$14K |
| 82043 |
|
2,288 |
2,147 |
$13K |
| 86803 |
|
852 |
777 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
254 |
239 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
1,745 |
1,496 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
160 |
152 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
179 |
171 |
$7K |
| 87088 |
|
761 |
722 |
$6K |
| 87275 |
|
480 |
429 |
$5K |
| 84439 |
|
560 |
536 |
$5K |
| 87276 |
|
376 |
358 |
$5K |
| 85651 |
|
1,285 |
1,203 |
$4K |
| 82947 |
|
1,104 |
1,058 |
$4K |
| 84436 |
|
581 |
543 |
$4K |
| 85007 |
|
1,202 |
1,076 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
72 |
69 |
$3K |
| 83970 |
|
49 |
49 |
$2K |
| 87490 |
|
94 |
94 |
$2K |
| 86592 |
|
445 |
422 |
$2K |
| 82570 |
|
303 |
254 |
$2K |
| 83655 |
|
78 |
78 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
126 |
119 |
$1K |
| 85730 |
|
152 |
133 |
$899.14 |
| 85610 |
|
169 |
148 |
$656.19 |
| 84479 |
|
88 |
87 |
$603.02 |
| 86704 |
|
51 |
37 |
$571.26 |
| 86706 |
|
48 |
38 |
$436.46 |
| 87340 |
|
51 |
37 |
$398.81 |
| 86708 |
|
32 |
25 |
$322.65 |
| 86709 |
|
32 |
25 |
$282.34 |
| 85027 |
|
37 |
30 |
$192.67 |
| 86038 |
|
12 |
12 |
$156.51 |
| 84478 |
|
24 |
24 |
$133.36 |
| 82950 |
|
24 |
24 |
$117.19 |
| 83550 |
|
12 |
12 |
$109.64 |
| 81001 |
|
34 |
26 |
$108.24 |
| 82465 |
|
24 |
24 |
$91.83 |
| 83540 |
|
13 |
13 |
$88.28 |
| 86140 |
|
12 |
12 |
$63.67 |
| 87177 |
|
12 |
12 |
$59.16 |
| 84156 |
|
18 |
12 |
$54.63 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
790 |
706 |
$1.47 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
452 |
442 |
$0.00 |
| 3044F |
|
19 |
19 |
$0.00 |
| 80050 |
General health panel |
98 |
69 |
$0.00 |
| 3060F |
|
18 |
18 |
$0.00 |
| 3048F |
|
12 |
12 |
$0.00 |